Frankfurt | Reuters — Germany’s Bayer will wrap up the US$63 billion takeover of Monsanto on Thursday and also retire the U.S. seed and chemical firm’s 117-year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. “Bayer will remain the company name. Monsanto will no
With deal to close this week, Bayer to retire Monsanto name
Bayer wins U.S. nod for Monsanto deal to create ag giant
Frankfurt/Washington | Reuters — Bayer won U.S. approval for its planned takeover of Monsanto after agreeing to sell about US$9 billion in assets, clearing a major hurdle for the US$62.5 billion deal that will create by far the largest seeds and pesticides maker. Makan Delrahim, who heads the U.S. Justice Department’s (DoJ) antitrust division, said
Singapore firm hikes Bayer stake in share sale
Frankfurt | Reuters — German drugmaker Bayer is raising three billion euros (C$4.67 billion) toward its planned US$62.5 billion takeover of seed and chemical firm Monsanto by selling a 3.6 per cent stake to Singapore’s state investment company Temasek. Bayer said it had struck a deal with Temasek under which it would issue shares with
Bayer to sell digital farming business to BASF
Frankfurt | Reuters — Germany’s Bayer plans to sell its digital farming business to BASF as part of changes to concessions it has offered to win over antitrust regulators for its proposed takeover of Monsanto . Bayer, which had previously only agreed to grant a licence to competitors, said on Wednesday that as part of
Bayer petitions Russian antitrust watchdog for more time in Monsanto case
Frankfurt/Moscow | Reuters — Bayer has taken Russia’s competition regulator to court over the watchdog’s investigation into the company’s planned takeover of Monsanto, a further hiccup in the US$64 billion deal amid intense antitrust scrutiny. A Bayer spokesman said the German company was petitioning the court in Russia to be given more time to discuss
Bayer offers asset sales for EU approval of Monsanto deal
Brussels/Frankfurt | Reuters — Bayer has offered to sell seeds and pesticides businesses to try to address EU competition concerns over its US$63.5 billion bid for U.S. rival Monsanto. The proposed remedies “are very significant and we are confident they fully address the European Commission’s concerns,” the German company said in a statement on Monday.
EU review of Bayer’s Monsanto bid postponed further
Frankfurt/Brussels | Reuters — Bayer’s quest to win regulatory approval for its planned takeover of Monsanto ran into further delays on Monday as European Union antitrust investigators extended their investigation by five working days until March 12. The ongoing proceedings would have given the German drugs and pesticides maker until midnight on Monday to offer
Bayer says needs more time for Monsanto deal approval
Monheim, Germany | Reuters — German drugs and pesticides group Bayer said Tuesday it was now likely to be early next year before it can complete its US$66 billion deal to acquire U.S. group Monsanto, later than previously expected. The European Commission has been scrutinizing the proposed takeover with a deadline of Jan. 8 but
EU starts in-depth probe of Bayer-Monsanto deal
Brussels/Frankfurt | Reuters — The European Commission has started an in-depth investigation of Bayer’s planned US$66 billion takeover of U.S. seeds group Monsanto, saying it was worried about competition in various pesticide and seeds markets. The deal would create the world’s largest integrated pesticides and seeds company, the Commission said, adding this limited the number
BASF ready to snatch seed bargains as rivals sell assets
Ludwigshafen, Germany | Reuters — BASF will consider buying seed assets that rivals are putting on the block to win antitrust approval for tie-ups, saying bargain prices could persuade BASF to overcome its traditional reluctance to expand into the seeds industry. Sources familiar with BASF’s thinking have said that competition regulators looking at potential buyers